Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Azo dyes in clothing textiles can be cleaved into a series of mutagenic aromatic amines which are not regulated yet.

Regulatory toxicology and pharmacology : RTP·2017
Same author

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.

Hepatology (Baltimore, Md.)·2012
Same author

Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.

Bioorganic & medicinal chemistry·2011
Same author

First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.

Journal of medicinal chemistry·2010
Same author

Computational toxicology--a tool for early safety evaluation.

Drug discovery today·2009
Same author

Chemical substructures in drug discovery.

Drug discovery today·2003

Related Experiment Video

Updated: Jul 8, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

In silico methods for early toxicity assessment.

Cedric Merlot1

  • 1GenKyoTex SA, 14 Chemin des Aulx, 1228 Plan Les Ouates, Geneva, Switzerland. cedric.merlot@genkyotex.com

Current Opinion in Drug Discovery & Development
|January 5, 2008
PubMed
Summary

Drug development faces challenges with declining new drugs and safety withdrawals. In silico toxicology offers an innovative, cost-effective solution for early safety prediction in drug discovery.

Area of Science:

  • Pharmacology and Toxicology
  • Computational Chemistry
  • Drug Discovery and Development

Background:

  • Declining rates of new drug approvals and recent safety-related drug withdrawals highlight critical issues in pharmaceutical research and development.
  • The pharmaceutical industry requires innovative strategies to enhance the efficiency and safety assessment of drug candidates.
  • Current drug safety evaluation methods can be time-consuming and expensive, necessitating more efficient alternatives.

Purpose of the Study:

  • To review recent advancements in in silico toxicology for predicting drug safety.
  • To discuss the growing importance and reasons for increased attention on computational approaches in drug discovery.
  • To highlight the potential of in silico methods as a cost-effective alternative for early-stage safety assessment.

More Related Videos

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

Related Experiment Videos

Last Updated: Jul 8, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

Main Methods:

  • Review of recent literature on in silico toxicology methodologies.
  • Analysis of computational approaches applied to predict drug safety profiles.
  • Discussion of the integration of in silico tools into the drug discovery pipeline.

Main Results:

  • Significant progress has been made in developing and validating in silico models for predicting various toxicity endpoints.
  • In silico toxicology provides valuable safety insights early in the drug discovery process, potentially reducing late-stage failures.
  • These computational methods offer a cost-effective complement or alternative to traditional in vitro and in vivo testing.

Conclusions:

  • In silico toxicology is a rapidly advancing field crucial for improving drug discovery efficiency and safety.
  • The adoption of in silico approaches is driven by the need for faster, cheaper, and more reliable methods for predicting drug safety.
  • Further research and validation are essential to fully realize the potential of in silico toxicology in pharmaceutical development.